University of Queensland
University of Queensland researchers have received $2 million from the National Health and Medical Research Council to improve understanding of prostrate and breast cancer and expedite the translation of research outcomes.
The Development Grants scheme funds early-stage health and medical projects with a clear path to commercialisation and strong potential for intellectual property.
NHMRC Development Grants recipients:
Professor Gregory Monteith - improve a leading therapy for the treatment of advanced and refractory prostate cancer.
Associate Professor David Muller - develop needle-free mRNA vaccines for the protection from and treatment of HER2+ breast cancer.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
